• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar

OINDPnews


Proveris Scientific
  • Home
  • News
    • Business
    • Features
    • Medical
    • Regulatory
    • Products and Services
    • People
  • Events
  • Suppliers
    • Supplier listing and advertising options
    • Capsules and blisters
    • Consultants
    • Contract research
    • Contract manufacturing
    • Devices
    • Education
    • Excipients
      • Clinical Technology
    • Filling equipment
    • Instruments
    • Particle manufacturing
    • Software and modeling
  • Jobs
  • Resources
    • Webinars
    • White papers
  • LGWP Propellants
    • HFA 152a
    • HFO-1234ze(E)
    • LGWP Regulation
  • Contact

Principal Scientist, Formulation and Process Development

Liquidia Technologies, Research Triangle Park, NC, is seeking a talented individual to join the pharmaceutical development team. This role will support research programs through development and scale-up of clinical and commercial formulations for pharmaceutical products including injectables, biologics and inhalation.

Job description
• Hands-on technical formulation leadership role in support of research/preformulation through clinical product development including process development and clinical trials material manufacturing in a range of dosage forms including nano and micro-sized particle drug delivery platforms.
• Develop and execute strategies related to product development, e.g. experimental design, data evaluation and formulation of relevant and scientifically based conclusions
• Develop a high level of expertise in process development of nano-and micron-sized particles
• Develop lyophilization, purification, sterilization, stability and packaging processes
• Investigate, troubleshoot and resolve technical issues associated with moving products from research through Phase I/II clinical studies
• Write technical reports and assist in the preparation of CMC sections for IND filings
• Partner and interact closely with Research, Clinical, Analytical, Manufacturing and Intellectual Property teams
• Hire and supervise technical staff; provide technical/procedure direction, training and mentoring
• Exchange and/or present technical information of specific projects
• Identify and manage appropriate supplier relationships as technical liaison
• Work across cross-functional teams and projects

Qualifications
• Formulation training with an advanced degree with minimum eight (8) years of formulation experience required
• Experience advancing multiple dosage forms and routes of administration strongly preferred
• Experience with therapeutic protein/vaccines drug development preferred
• Experience with multiple classes of drug products strongly preferred
• Experience working with colloidal dosage forms strongly preferred
• Strong experience with experimental design/evaluation
• Must be a creative, problem solving, detail oriented person with strong analytical skills
• Excellent oral and written communication skills
• Ability to manage and motivate scientific teams. Previous management experience strongly preferred
• Experience with GLP/GMP and IND filings required
• Ability to thrive in a multidisciplinary team environment is essential for success

Company Description
Liquidia Technologies is a privately-held clinical stage company focused on advancing vaccines and therapeutics that leverage the PRINT®technology for design and manufacture of engineered particles. The PRINT®technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process. In addition to its own products, Liquidia licenses its PRINT®particle technology and its GMP manufacturing capabilities to support proprietary programs advanced by collaborators.

Apply for the position

Share

published on June 20, 2012

Primary Sidebar

Sign up for our free weekly newsletter

Upcoming Events
Sponsored by Intertek

Want information about upcoming OINDP-related events delivered directly to your inbox? click here

  • June 17-June 18: Rescon Europe 2025, Paris, France
  • June 19-June 20: Metered Dose Inhaler (MDI) Technology Training Course, online
  • June 22-June 25: ISAM Congress 2025, Washington, DC, USA
  • June 25-June 25: SMI.London 2025, London, UK
  • September 18-September 19: IPAC-RS Nasal Innovation Forum, West Trenton, NJ, USA
  • See all upcoming events

    Secondary Sidebar

    Suppliers

    Capsules and blisters
    Consultants
    Contract research
    Contract manufacturing
    Devices
    Education
    Excipients
    Filling equipment
    Instruments
    Particle manufacturing
    Software and modeling
    Aptar Pharma banner
    © 2025 OINDPnews